512 related articles for article (PubMed ID: 25640596)
1. Conceptual models for the initiation of hepatitis B virus-associated hepatocellular carcinoma.
Tu T; Budzinska MA; Shackel NA; Jilbert AR
Liver Int; 2015 Jul; 35(7):1786-800. PubMed ID: 25640596
[TBL] [Abstract][Full Text] [Related]
2. Hepatitis B virus and microRNAs: Complex interactions affecting hepatitis B virus replication and hepatitis B virus-associated diseases.
Lamontagne J; Steel LF; Bouchard MJ
World J Gastroenterol; 2015 Jun; 21(24):7375-99. PubMed ID: 26139985
[TBL] [Abstract][Full Text] [Related]
3. Molecular mechanisms of HBV-associated hepatocarcinogenesis.
Guerrieri F; Belloni L; Pediconi N; Levrero M
Semin Liver Dis; 2013 May; 33(2):147-56. PubMed ID: 23749671
[TBL] [Abstract][Full Text] [Related]
4. Significance of hepatitis virus infection in the oncogenic initiation of hepatocellular carcinoma.
Sukowati CH; El-Khobar KE; Ie SI; Anfuso B; Muljono DH; Tiribelli C
World J Gastroenterol; 2016 Jan; 22(4):1497-512. PubMed ID: 26819517
[TBL] [Abstract][Full Text] [Related]
5. Integrative analysis of aberrant Wnt signaling in hepatitis B virus-related hepatocellular carcinoma.
Ding SL; Yang ZW; Wang J; Zhang XL; Chen XM; Lu FM
World J Gastroenterol; 2015 May; 21(20):6317-28. PubMed ID: 26034368
[TBL] [Abstract][Full Text] [Related]
6. Promyelocytic leukaemia protein links DNA damage response and repair to hepatitis B virus-related hepatocarcinogenesis.
Chung YL; Wu ML
J Pathol; 2013 Aug; 230(4):377-87. PubMed ID: 23620081
[TBL] [Abstract][Full Text] [Related]
7. Association of a potential functional pre-miR-218 polymorphism and its interaction with hepatitis B virus mutations with hepatocellular carcinoma risk.
Han Y; Pu R; Han X; Zhao J; Li W; Yin J; Zhang Y; Shen Q; Xie J; Zhang Q; Jiang S; Li J; Zhang H; Wang H; Cao G
Liver Int; 2014 May; 34(5):728-36. PubMed ID: 24118778
[TBL] [Abstract][Full Text] [Related]
8. Hepatitis B virus-induced hepatocellular carcinoma.
Xu C; Zhou W; Wang Y; Qiao L
Cancer Lett; 2014 Apr; 345(2):216-22. PubMed ID: 23981576
[TBL] [Abstract][Full Text] [Related]
9. Hepatitis B virus pre-S2 mutant large surface protein inhibits DNA double-strand break repair and leads to genome instability in hepatocarcinogenesis.
Hsieh YH; Chang YY; Su IJ; Yen CJ; Liu YR; Liu RJ; Hsieh WC; Tsai HW; Wang LH; Huang W
J Pathol; 2015 Jul; 236(3):337-47. PubMed ID: 25775999
[TBL] [Abstract][Full Text] [Related]
10. Expression profile of nine novel genes differentially expressed in hepatitis B virus-associated hepatocellular carcinomas.
Kim MY; Park E; Park JH; Park DH; Moon WS; Cho BH; Shin HS; Kim DG
Oncogene; 2001 Jul; 20(33):4568-75. PubMed ID: 11494152
[TBL] [Abstract][Full Text] [Related]
11. The direct and indirect roles of HBV in liver cancer: prospective markers for HCC screening and potential therapeutic targets.
Ringelhan M; O'Connor T; Protzer U; Heikenwalder M
J Pathol; 2015 Jan; 235(2):355-67. PubMed ID: 25196558
[TBL] [Abstract][Full Text] [Related]
12. Up-regulation of human cervical cancer proto-oncogene contributes to hepatitis B virus-induced malignant transformation of hepatocyte by down-regulating E-cadherin.
Li J; Dai X; Zhang H; Zhang W; Sun S; Gao T; Kou Z; Yu H; Guo Y; Du L; Jiang S; Zhang J; Zhou Y
Oncotarget; 2015 Oct; 6(30):29196-208. PubMed ID: 26470691
[TBL] [Abstract][Full Text] [Related]
13. Impacts of human leukocyte antigen DQ genetic polymorphisms and their interactions with hepatitis B virus mutations on the risks of viral persistence, liver cirrhosis, and hepatocellular carcinoma.
Ji X; Zhang Q; Li B; Du Y; Yin J; Liu W; Zhang H; Cao G
Infect Genet Evol; 2014 Dec; 28():201-9. PubMed ID: 25281206
[TBL] [Abstract][Full Text] [Related]
14. Direct effects of hepatitis B virus-encoded proteins and chronic infection in liver cancer development.
Ringelhan M; Heikenwalder M; Protzer U
Dig Dis; 2013; 31(1):138-51. PubMed ID: 23797136
[TBL] [Abstract][Full Text] [Related]
15. Recent advances in the research of hepatitis B virus-related hepatocellular carcinoma: epidemiologic and molecular biological aspects.
Kao JH; Chen PJ; Chen DS
Adv Cancer Res; 2010; 108():21-72. PubMed ID: 21034965
[TBL] [Abstract][Full Text] [Related]
16. Hepatocellular carcinoma and hepatitis B virus.
Chan HL; Sung JJ
Semin Liver Dis; 2006 May; 26(2):153-61. PubMed ID: 16673293
[TBL] [Abstract][Full Text] [Related]
17. Molecular cytogenetic evaluation of virus-associated and non-viral hepatocellular carcinoma: analysis of 26 carcinomas and 12 concurrent dysplasias.
Zondervan PE; Wink J; Alers JC; IJzermans JN; Schalm SW; de Man RA; van Dekken H
J Pathol; 2000 Oct; 192(2):207-15. PubMed ID: 11004697
[TBL] [Abstract][Full Text] [Related]
18. Molecular targets for therapy of hepatitis B virus-induced hepatocellular carcinoma.
Tharayil VS; Roberts LR
Minerva Gastroenterol Dietol; 2006 Dec; 52(4):387-406. PubMed ID: 17108869
[TBL] [Abstract][Full Text] [Related]
19. Associations between activation-induced cytidine deaminase/apolipoprotein B mRNA editing enzyme, catalytic polypeptide-like cytidine deaminase expression, hepatitis B virus (HBV) replication and HBV-associated liver disease (Review).
He X; Li J; Wu J; Zhang M; Gao P
Mol Med Rep; 2015 Nov; 12(5):6405-14. PubMed ID: 26398702
[TBL] [Abstract][Full Text] [Related]
20. Type II ground-glass hepatocytes as a marker of hepatocellular carcinoma in chronic hepatitis B.
Mathai AM; Alexander J; Kuo FY; Torbenson M; Swanson PE; Yeh MM
Hum Pathol; 2013 Aug; 44(8):1665-71. PubMed ID: 23574780
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]